MediPal : Notice Regarding Progress of Acquisition of Treasury Stock

November 2, 2023

MEDIPAL HOLDINGS CORPORATION

Representative: Shuichi Watanabe, Representative Director, President and CEO

Code number: 7459 (Prime Market, Tokyo Stock Exchange)

Contact: Yuji Sakon,

Managing Director, General Manager of Administration Division

Tel: [phone]

Notice Regarding Progress of Acquisition of Treasury Stock

MEDIPAL HOLDINGS CORPORATION has implemented the acquisition of treasury stock based on the provisions of the Articles of Incorporation pursuant to Article 459, Paragraph 1 of the Companies Act, which was resolved at the Board of Directors meeting held on May 12, 2023. Details follow below.

(1) Class of stock acquired	Common stock
(2)	Total number of shares	591,300 shares (on an Execution base)
(3)	acquired:
Total amount acquired	JPY 1,472,747,236
(4)	Period of acquisition	From October 1, 2023 to October 31, 2023
(5)	Method of acquisition	Market buying on the Tokyo Stock Exchange

Reference

1. Details of the resolution at the Board of Directors meeting held on May 12, 2023

(1)	Class of stock to be acquired	Common stock
	Total number of shares to be	Up to 5,800,000 shares
(2)	(2.7% of the total number of common stock issued
	acquired	(excluding treasury stock))
(3)	Total acquisition cost	Up to 10 billion yen
(4)	Period of acquisition	From May 15, 2023 to December 29, 2023
(5)	Method of acquisition	Market buying on the Tokyo Stock Exchange

2. Total number of shares and amount acquired pursuant to the above resolution as of October 31, 2023

(1)	Total number of shares acquired	3,085,600 shares (on an Execution base)
(2)	Total amount acquired	JPY 7,413,792,146

# # #

The English version of this document is a translation of the Japanese original and is provided for information purposes only. While reasonable efforts have been made to provide an accurate translation, no liability is assumed by MEDIPAL HOLDINGS CORPORATION for any errors, omissions, or ambiguities in the translation. In the event of any inconsistency or conflict between the English version and the Japanese original, the Japanese original shall prevail.